NCT03823300 A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE) Status COMPLETED Phase PHASE3
NCT03823287 A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA) Status COMPLETED Phase PHASE3
NCT03766425 Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy. Status COMPLETED Phase EARLY_PHASE1
NCT03710564 Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections Status TERMINATED Phase PHASE3
NCT03622593 A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT03622580 A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) Status COMPLETED Phase PHASE3
NCT03481660 A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT03481634 Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema Status COMPLETED Phase PHASE3
NCT03452527 Open-Label Study of Intravitreal ICON-1 in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) Status TERMINATED Phase PHASE2
NCT03397264 A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema Status COMPLETED Phase PHASE1/PHASE2
NCT03396861 Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept Status TERMINATED Phase PHASE1
NCT03370380 Aflibercept in Patients With Pigment Epithelial Detachments (PED) Status COMPLETED Phase N/A
NCT03313401 Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration Status COMPLETED Phase N/A
NCT03279289 Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen Status COMPLETED Phase PHASE2
NCT03264274 Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE2
NCT03249740 A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration Status COMPLETED Phase PHASE1
NCT03186326 Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer Status COMPLETED Phase PHASE2
NCT03085784 Intravitreal Aflibercept Injection for Radiation Retinopathy Trial Status UNKNOWN Phase PHASE2
NCT03043729 mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer Status COMPLETED Phase PHASE2